AstraZeneca's R&D program developed a COVID-19 vaccine and delivered 3 Bn doses in 2022
Register to read the full analysis —or— Upgrade to access more features
#Vaccine
#covid pandemic
#AstraZeneca
#WHO
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.